COVID-19 Severity in Multiple Sclerosis: Putting Data Into Context.

Maria Pia Sormani Irene Schiavetti Luca Carmisciano Cinzia Cordioli Massimo FilippiMarta RadaelliPaolo ImmovilliMarco CapobiancoNicola De RossiGiampaolo BrichettoEleonora CoccoCinzia ScandellariPaola CavallaIlaria PesciAntonio ZitoPaolo ConfalonieriGirolama Alessandra MarfiaPaola PeriniMatilde IngleseMaria TrojanoVincenzo Brescia MorraGioacchino TedeschiGiancarlo ComiMario Alberto BattagliaFrancesco PattiMarco Salvettinull null

Published in: Neurology(R) neuroimmunology & neuroinflammation (2021)

Overall, the MS cohort had a risk of severe events that is twice the risk than the age- and sex-matched Italian population. This excess of risk is mainly explained by the EDSS score and comorbidities, whereas a residual increase of hospitalization risk was observed in patients on anti-CD20 therapies and a decrease in people on interferon.

Keyphrases

multiple sclerosis
end stage renal disease
coronavirus disease
sars cov
ejection fraction
newly diagnosed
chronic kidney disease
big data
electronic health record
ms ms
machine learning
patient reported
data analysis